Bristol-Myers Squibb CompanyBMYNYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-11.7%
5Y CAGR-7.1%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-11.7%/yr
vs -3.1%/yr prior
5Y CAGR
-7.1%/yr
Recent deceleration
Acceleration
-8.6pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.28 | -3.8% |
| 2024 | 2.37 | +0.6% |
| 2023 | 2.36 | -29.0% |
| 2022 | 3.32 | +11.2% |
| 2021 | 2.99 | -9.4% |
| 2020 | 3.29 | -21.3% |
| 2019 | 4.19 | +11.3% |
| 2018 | 3.76 | -22.5% |
| 2017 | 4.85 | -3.5% |
| 2016 | 5.03 | - |